Is it true that artificial sweeteners cause cancer?
There are signals that high consumption of artificial sweeteners is associated with a slightly elevated cancer risk, but no proven causal relationship exists. Moderate use does not need to be dramatised, but using them as a "safe alternative" for weight management is also not supported by evidence.
Large observational studies show a moderately elevated cancer risk in people who consume a lot of artificial sweeteners. In a French cohort of more than 102,000 participants, the probability of cancer in higher consumers was around 13 to 15% greater than in non-consumers. Aspartame and acesulfame-K showed comparable signals. That sounds alarming, but this type of research cannot establish cause and effect.
A meta-analysis combining 25 observational studies, with nearly 3.7 million participants, found no consistent association with cancer incidence worldwide. In European studies there was a small statistically elevated risk (7%). The studies therefore do not completely contradict one another, but neither do they fully agree. Two serious methodological problems recur throughout: confounding factors (people who drink a lot of diet products also live differently in other ways) and reverse causality (people who are already ill or overweight more often reach for sweeteners). Those two factors can largely or fully explain the associations found.
A comprehensive review of hundreds of toxicological and epidemiological findings concluded that there is in fact no evidence of an elevated cancer risk. A caveat: that study was funded by the sweetener industry, which undermines its independence.
Computational studies and animal experiments suggest mechanisms by which sweeteners could interact with cancer-related proteins. But these kinds of computational models and cell studies are purely hypothesis-generating; they say nothing yet about what actually happens in a human body.
What the science does show with reasonable consistency is that high intake of artificial sweeteners is associated with an elevated risk of cardiovascular disease, type 2 diabetes, and possibly higher mortality. Whether that is causal, or how large the association is at moderate consumption levels, is not clear. A concrete point of reference: the WHO now advises against using sweeteners as a structural weight-management strategy, partly because meta-analyses show no benefit for weight or blood sugar.
All claims are based on observational studies and meta-analyses of observational studies (no RCTs), an industry-funded review, and exploratory computational research. PMIDs: 35324894, 36145117, 36870410, 39780215, 38423749, 36638072, 37490630, 36364710.